Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB)
CUSIP: 207523101
Q3 2023 13F Holders as of 30 Sep 2023
- Type / Class
- Equity / Ordinary Shares, par value $0.000174 per share
- Shares outstanding
- 55,803,824
- Total 13F shares
- 10,078,543
- Share change
- -60,413
- Total reported value
- $8,221,166
- Price per share
- $0.80
- Number of holders
- 12
- Value change
- -$60,098
- Number of buys
- 3
- Number of sells
- 4
Quarterly Holders Quick Answers
What is CUSIP 207523101?
CUSIP 207523101 identifies CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 207523101:
Top shareholders of CNTB - Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| RA CAPITAL MANAGEMENT, L.P. |
13F
|
Company |
13%
|
6,991,003
|
$7,899,833 | — | 30 Jun 2023 | |
| BlackRock Finance, Inc. |
13F
|
Company |
2%
|
1,125,262
|
$1,271,546 | — | 30 Jun 2023 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
650,000
|
$734,500 | — | 30 Jun 2023 | |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AMERICAS (LLC) |
13F
|
Company |
1.1%
|
603,900
|
$670,329 | — | 30 Jun 2023 | |
| Kynam Capital Management, LP |
13F
|
Company |
0.96%
|
535,005
|
$602,640 | — | 30 Jun 2023 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.39%
|
219,501
|
$243,645 | — | 30 Jun 2023 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
95,500
|
$108,000 | — | 30 Jun 2023 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0.09%
|
48,372
|
$53,693 | — | 30 Jun 2023 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.05%
|
26,867
|
$30,360 | — | 30 Jun 2023 | |
| TWO SIGMA INVESTMENTS, LP |
13F
|
Company |
0.04%
|
23,586
|
$26,652 | — | 30 Jun 2023 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.03%
|
19,032
|
$21,125 | — | 30 Jun 2023 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.02%
|
10,470
|
$11,622 | — | 30 Jun 2023 | |
| RHUMBLINE ADVISERS |
13F
|
Company |
0.02%
|
9,935
|
$11,027 | — | 30 Jun 2023 | |
| FMR LLC |
13F
|
Company |
0%
|
24
|
$26 | — | 30 Jun 2023 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
1
|
$1 | — | 30 Jun 2023 |
Institutional Holders of Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) as of Q3 2023
As of 30 Sep 2023,
Connect Biopharma Holdings Ltd - Ordinary Shares, par value $0.000174 per share (CNTB) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
10,078,543 shares.
The largest 10 holders included
RA CAPITAL MANAGEMENT, L.P., BlackRock Inc., ADAGE CAPITAL PARTNERS GP, L.L.C., UBS OCONNOR LLC, Kynam Capital Management, LP, RENAISSANCE TECHNOLOGIES LLC, JPMORGAN CHASE & CO, GEODE CAPITAL MANAGEMENT, LLC, TWO SIGMA INVESTMENTS, LP, and RHUMBLINE ADVISERS.
This page lists
12
institutional shareholders reporting positions in this security
for the Q3 2023 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2023 vs Q2 2023 Across Filers
Q2 2023 holders
15
Q3 2023 holders
12
Holder diff
-3
| Investor | Q2 2023 Shares | Q3 2023 Shares | Share Diff | Share Chg % | Q2 2023 Value $ | Q3 2023 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.